
Full profile: /officials/Y000067
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
Previously
The bill would establish new safety standards and oversight procedures for pharmaceutical drugs, likely including requirements for manufacturers to report adverse effects more quickly and for the FDA to have stronger authority to monitor drug safety after approval. It would affect drug companies, patients who take medications, and healthcare providers by potentially requiring more rigorous testing and transparency about drug risks. The goal appears to be preventing unsafe drugs from reaching patients and ensuring faster removal of dangerous medications from the market.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.